The drug distributor will fold the clinical research and biopharma commercialization firm into its oncology unit once the ...

McKesson Corporation is expanding its drug development and commercialization capacity to the tune of $2.25 billion. | The ...

Aug 25 (Reuters) - U.S. drug distributor McKesson said on Tuesday it would buy privately held Precision Medicine Group in a ...

Computers are my lifelong obsession. I wrote my first laptop review in 2005 for NotebookReview.com, continued with a consistent PC-reviewing gig at Computer Shopper in 2014, and moved to PCMag in 2018 ...

Biomarker-driven clinical trials are becoming more complex as precision medicine expands across therapeutic areas.

Imagine being told that everyone needs to wear one specific pair of low-riding jeans at all times regardless of their age, body configuration, surroundings, or life situation. This could leave you ...

Precision medicine promises to tailor health care to the individual. But what happens when entire communities are left out of the data that drives that tailoring? When I embarked on cardiovascular ...

Tempus AI, Inc. made a timely move to acquire the Personalis cancer monitoring tests to advance AI-driven precision medicine.

No, that spinning cap on your screwdriver isn't a fidget toy. Here's what this tiny tool's extra feature does and how it can ...

Aug 25 (Reuters) - U.S. drug distributor McKesson said on Tuesday it would buy clinical research and biopharma ...